| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-87 |
Sentence |
denotes |
Site-specific characterisation of SARS-CoV-2 spike glycoprotein receptor binding domain |
| T2 |
89-97 |
Sentence |
denotes |
Abstract |
| T3 |
98-106 |
Sentence |
denotes |
Abstract |
| T4 |
107-273 |
Sentence |
denotes |
The novel coronavirus SARS-CoV-2, the infective agent causing COVID-19, is having a global impact both in terms of human disease as well as socially and economically. |
| T5 |
274-482 |
Sentence |
denotes |
Its heavily glycosylated spike glycoprotein is fundamental for the infection process, via its receptor binding domains interaction with the glycoprotein angiotensin converting enzyme 2 on human cell surfaces. |
| T6 |
483-668 |
Sentence |
denotes |
We therefore utilized an integrated glycomic and glycoproteomic analytical strategy to characterise both N- and O- glycan site specific glycosylation within the receptor binding domain. |
| T7 |
669-830 |
Sentence |
denotes |
We demonstrate the presence of complex type N-glycans with unusual fucosylated LacdiNAc at both sites N331 and N343 and a single site of O-glycosylation on T323. |
